insights_auto
Why is 207940 up 2.96%?
Dive Deeperchevron_right
207940:KRX
Samsung Biologics Co Ltd
₩1,495,000.00
arrow_upward
+2.96%(+43,000.00) 1D
Nov 4, 3:30:14 PM GMT+9 · KRW
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 207940...
Open
₩1,432,000
High
₩1,500,000
Low
₩1,401,000
Mkt. cap
72.60T
Avg. vol.
65.48K
Volume
73.42K
P/E ratio
32.57
52-wk high
₩1,973,600
52-wk low
₩1,150,000
EPS
₩45,897
Shares outstanding
46.29M
No. of employees
5K
Open
₩1,432,000
High
₩1,500,000
Low
₩1,401,000
Mkt. cap
72.60T
Avg. vol.
65.48K
Volume
73.42K
P/E ratio
32.57
52-wk high
₩1,973,600
52-wk low
₩1,150,000
EPS
₩45,897
Shares outstanding
46.29M
No. of employees
5K
News stories
From web sources and news partners
Profile
Samsung Biologics Co., Ltd. is a global contract development and manufacturing organization headquartered in Songdo, Incheon, South Korea. The biotech division of Samsung Group, its core services range from late discovery to large-scale commercial manufacturing. The company focuses on monoclonal antibodies, bispecific antibodies, antibody-drug conjugates, and mRNA vaccines.
The company has partnered with pharmaceutical companies such as Pfizer, GlaxoSmithKline, Eli Lilly, AstraZeneca and Bristol-Myers Squibb. Wikipedia
About Samsung Biologics Co Ltd
CEOJohn Rim
Employees5.33K
Founded2011
Headquarters-
SectorHealth care
Industry-
Websitesamsungbiologics.com